Return to search

BioHeart Files for IPO

BioHeart, a Sunrise, Florida-based developer of heart muscle regeneration therapies, has filed for a $45 million IPO, an increase from the original $35 million it intended to raise in its initial filing in February. It plans to trade on the Nasdaq under ticker symbol BHRT, with BMO Capital Markets and Janney Montgomery Scott serving as co-lead underwriters. BioHeart has raised around $40 million in VC funding since 2000, from firms like Ascent Medical Ventures, Guidant, Tyco Capital and Advent-Moro Equity Partners.